Molecular markers of blood activation allow measurement of pathological processes, as the result of abnormal blood procoagulant
activity, during the silent clinical phase, or early during the disease evolution. They provide information on disease evolution, its
diagnosis or prognosis, or on efficacy of anti-thrombotic therapies.
THROMBOSIS AND VASCULAR DISEASES
|
|
